Search results
Results From The WOW.Com Content Network
In the United States, prescription monitoring programs ( PMPs) or prescription drug monitoring programs ( PDMPs) are state-run programs which collect and distribute data about the prescription and dispensation of federally controlled substances and, depending on state requirements, other potentially abusable prescription drugs. PMPs are meant to help prevent adverse drug-related events such as ...
The Medicare Prescription Drug, Improvement, and Modernization Act, [1] also called the Medicare Modernization Act or MMA, is a federal law of the United States, enacted in 2003. [2] It produced the largest overhaul of Medicare in the public health program's 38-year history.
The California Department of Alcohol and Drug Programs ( ADP) was a California state agency concerned with substance abuse prevention and treatment. Created by the California Legislature in 1978, ADP brought together the Governor's Office of Alcoholism and the California Department of Health's Division of Substance Abuse to form the single state authority for substance abuse prevention and ...
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the drug that can save someone's life during an opioid overdose, under a deal ...
The Controlled Substances Act (CSA), Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, is the legal foundation of the government's fight against the abuse of drugs and other substances. This law is a consolidation of numerous laws regulating the manufacture and distribution of narcotics, stimulants, depressants, hallucinogens, anabolic steroids, and chemicals used in ...
California Proposition 36, the Substance Abuse and Crime Prevention Act of 2000, was an initiative statute that permanently changed state law to allow qualifying defendants convicted of non-violent drug possession offenses to receive a probationary sentence in lieu of incarceration.
Risk Evaluation and Mitigation Strategies ( REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or generic drugs. [1] The REMS program was formalized in 2007.
Ron Brancato from the Pelham Bay area of Bronx New York, Program Director and former resident of Synanon, California. Synanon was the only other drug rehabilitation program until Daytop Village opened.